Overcoming barriers to facilitate the regulation of multi-centre regenerative medicine clinical trials
Abstract In the context of regenerative medicine and cellular therapies, the treatment under study often targets a less common disease or condition for which recruitment of a large number of research participants at any given site is challenging, if not impossible. One way to overcome this challenge...
Main Authors: | Erika Kleiderman, Audrey Boily, Craig Hasilo, Bartha Maria Knoppers |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-11-01
|
Series: | Stem Cell Research & Therapy |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13287-018-1055-2 |
Similar Items
-
Ethics of research on stem cells and regenerative medicine: ethical guidelines in the Islamic Republic of Iran
by: Leila Afshar, et al.
Published: (2020-09-01) -
Ethical and regulatory issues of stem cell-derived 3-dimensional organoid and tissue therapy for personalised regenerative medicine
by: Alexander R. Harris, et al.
Published: (2022-12-01) -
Patient- or person-centred practice in medicine? – A review of concepts
by: Jakobus M. Louw, et al.
Published: (2017-10-01) -
Regenerative biology and medicine /
by: Stocum, David L., author
Published: (2012) -
Principles of regenerative medicine /
by: Atala, Anthony, 1958-
Published: (2008)